Reactive Oxygen Species Generation and Atherosclerosis
Witold N. Nowak,Jiacheng Deng,Xiong Z. Ruan,Qingbo Xu
DOI: https://doi.org/10.1161/atvbaha.117.309228
2017-01-01
Abstract:HomeArteriosclerosis, Thrombosis, and Vascular BiologyVol. 37, No. 5Reactive Oxygen Species Generation and Atherosclerosis Free AccessReview ArticlePDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessReview ArticlePDF/EPUBReactive Oxygen Species Generation and Atherosclerosis Witold N. Nowak, Jiacheng Deng, Xiong Z. Ruan and Qingbo Xu Witold N. NowakWitold N. Nowak From the Cardiovascular Division, King’s BHF Centre, King’s College London, United Kingdom (W.N.N., J.D., Q.X.); Centre for Nephrology and Urology, Health Science Centre, Shenzhen University, China (X.Z.R.); and Centre for Nephrology, University College London, United Kingdom (X.Z.R.). Search for more papers by this author , Jiacheng DengJiacheng Deng From the Cardiovascular Division, King’s BHF Centre, King’s College London, United Kingdom (W.N.N., J.D., Q.X.); Centre for Nephrology and Urology, Health Science Centre, Shenzhen University, China (X.Z.R.); and Centre for Nephrology, University College London, United Kingdom (X.Z.R.). Search for more papers by this author , Xiong Z. RuanXiong Z. Ruan From the Cardiovascular Division, King’s BHF Centre, King’s College London, United Kingdom (W.N.N., J.D., Q.X.); Centre for Nephrology and Urology, Health Science Centre, Shenzhen University, China (X.Z.R.); and Centre for Nephrology, University College London, United Kingdom (X.Z.R.). Search for more papers by this author and Qingbo XuQingbo Xu From the Cardiovascular Division, King’s BHF Centre, King’s College London, United Kingdom (W.N.N., J.D., Q.X.); Centre for Nephrology and Urology, Health Science Centre, Shenzhen University, China (X.Z.R.); and Centre for Nephrology, University College London, United Kingdom (X.Z.R.). Search for more papers by this author Originally published1 May 2017https://doi.org/10.1161/ATVBAHA.117.309228Arteriosclerosis, Thrombosis, and Vascular Biology. 2017;37:e41–e52Atherosclerosis is the key component of most cardiovascular diseases, including stroke and myocardial infarction.1–3 An inflamed endothelium recruits inflammatory cells, such as monocytes, via the expression of various mediators and chemokines.4–6 This, in addition to the accumulation of cholesterol and smooth muscle cells (SMCs) in the intima, leads to the transformation of monocytes into foam cells, which consume dead cells and lipids.7–9 The atherogenic process involves multiple cell types, that is, endothelial cells (ECs),10 SMCs,11 immune cells,12 and stem/progenitor cells,13 in which levels of both intracellular and extracellular reactive oxygen and nitrogen species play a fundamental role in vascular cell homoeostasis and eventually affects the development of atherosclerosis.14 Fine-tuning of cellular redox status is a prerequisite for the well-being of vascular system. Although too much oxidative stress can be detrimental, some basal levels are crucial for proper cell signaling. Recently, a number of publications in ATVB and other journals have demonstrated substantial progress in research into oxidative stress vascular disease, especially atherosclerosis.14–17 In the present article, we highlight these updated publications, providing insights into the mechanisms of reactive oxygen species (ROS) generation in pathophysiological conditions of the vessel wall, and the contribution of redox imbalance to lesion formation via influencing vascular cell (dys)functions.Oxidative stress is defined as a cellular condition where the damaging effect of oxidant is greater than the beneficial effect of antioxidants. Major oxidants are based on O2 molecules, which are taken in during respiration, with higher reactivity than molecular O2, and are known as ROS.14 ROS are, thus, broadly defined as oxygen-containing chemical species with higher reactive properties. Major ROS include superoxide (O2·−) and hydroxyl (HO·) free radicals, as well as nonradical molecules, such as hydrogen peroxide (H2O2). Primary sources of oxidative stress in vessel wall are mitochondria,18 uncoupled nitric oxide synthase,19 lipoxygenase,20 myeloperoxidase,21 xanthine oxidase (XO),22 and importantly NAD(P)H oxidases23 (Figure 1). However, the influence of ROS-producing enzymes, especially NADPH oxidases, in the development of atherosclerosis is ambiguous.23 Nox4-derived mitochondrial ROS were detrimental in older mice with atherosclerosis,24 and dominant negative mutant form of Nox4 decreased atherosclerosis formation.25 On the other hand, Nox4 knockout aggravated atherosclerosis,26 especially in diabetic mice.27Download figureDownload PowerPointFigure 1. Sources of ROS in the vascular wall. LOX indicates lipoxygenase; MPO, myeloperoxidase; NOS, nitric oxide synthase; NOX, NAD(P)H oxidase; SOD, superoxide dismutase; and XO, xanthine oxidase.High levels of oxidative stress can be counteracted by complex antioxidant cell systems that are crucial for the maintenance of redox balance. The key player that plays a primary role in the regulation of antioxidant gene response is nuclear factor erythroid 2–related factor 2 (Nrf2),28 encoded by the Nfe2l2 gene. However, depending on the mouse model used and cell type analyzed or even sex of animals, Nrf2 showed both pro- and antiatherogenic properties.29 Wire injury induces higher neointima formation in Nfe2l2−/− mice than in control animals.30,31 Global knockout of Nfe2l2 in Apoe−/− mice decreased the formation of atherosclerotic lesions.32–35 Transplantation of Nfe2l2−/− bone marrow to Apoe−/−35 or Ldlr−/−36 recipients attenuated atherosclerosis, what underlines proatherogenic activity of Nrf2 in myeloid cells. However, increased formation of plaque in Ldr−/− mice transplanted with Nfe2l2−/− bone marrow was also reported.37 On the other hand, activation of Nrf2 in SMCs38,39 or ECs40 was protective against atherosclerosis. Furthermore, knockouts of potent antioxidant enzymes, for example, Gpx1,41Prdx2,42Hmox1,43 can also aggravate plaque formation. Importantly, basal levels of ROS were crucial for the activation of endoplasmic reticulum (ER) stress response,44 maintenance of SMC contractile phenotype,45 or differentiation of SMC from stem cells.46,47 Thus, the regulation of oxidative stress is complex, and investigation of its role in the pathogenesis of atherosclerosis remains an important subject of many studies. Therefore, the aim of this article is to summarize the latest advances in the research on the role of oxidative stress in the modulation of cells that can affect the development of atherosclerosis.Endothelial CellsThe healthy endothelium is key for the functional maintenance of vascular system.48,49 Sustained ROS levels can contribute to the endothelial dysfunction, and further to its senescence and activation of an inflammatory response, and in turn lead to the development of atherosclerosis. NADPH oxidases, especially Nox4, play an ambiguous role in the development of atherosclerosis. Craige et al50 reported recently that Apoe−/− mice with endothelial-specific Nox4 overexpression (Apoe−/− Nox4EC) showed significantly smaller lesions than control Apoe−/− animals. Apoe−/− Nox4EC aortas contained, however, similar numbers of macrophages and did not differ from Apoe−/− mice in expressions of macrophage or inflammatory markers, that is, E- and P-selectin, VCAM1 (vascular cell adhesion molecule 1), and ICAM1 (intercellular adhesion molecule 1). On the contrary, Apoe−/− Nox4EC aortas contained higher Treg numbers, while numbers of effector T cells and plasma CXCL9 (chemokine [C-X-C motif] ligand 9) concentration were lower than in Apoe−/− controls. Both mouse lung ECs and human aortic ECs overexpressing Nox4 showed attenuated CXCL9 induction after interferon-γ.50In another study, downregulation of Nox4 in human aortic ECs, cultured under high glucose conditions, resulted in the increase of profibrotic CTGF (connective tissue growth factor), while endothelial H2O2 decreased.51 On the other hand, Nox4 overexpression caused a significant reduction in p-SMAD3 (phosphorylated mothers against decapentaplegic homolog 3). In diabetic Apoe−/− mice, aortic expression of both Nox1 and Nox4 increases after 10 weeks of diabetes mellitus. Further development of atherosclerosis in diabetic Apoe−/− mice led to the decline in Nox4 expression, while levels of Nox1 remained high. Importantly, Nox4 expression in carotid plaques is lower in patients with cardiovascular events or diabetes mellitus. Nox4 deletion in diabetic Apoe−/− mice increased, while deletion of Nox1 in diabetic Apoe−/− attenuated plaque formation in comparison to control diabetic Apoe−/− mice. Nox4-deficient Apoe−/− diabetic mice showed lower levels of aortic H2O2 while superoxide levels were increased. Nox1 deletion resulted in a decrease in both superoxide and tyrosine nitration. Furthermore, diabetic Nox4−/−Apoe−/− showed elevated serum and aortic MCP-1 (monocyte chemotactic protein 1) concentrations, as well as macrophage accumulation in the vessel wall. Nox4 knockdown also led to the increase of fibrillar collagens I and III in plaques, which was associated with elevated transforming growth factor-β expression and p-SMAD3 levels.51Nox4 and H2O2 regulate the response to ER stress, which is crucial for the induction of unfolded protein response.44 Importantly, both ER stress and response to it are activated during the development of atherosclerosis.52 Wu et al44 showed that tunicamycin-induced ER stress elevated H2O2 in ER in the Nox4-dependent way. Increased H2O2 concentrations led in turn to the oxidation of sarco/endoplasmic reticulum Ca2+-ATPase and an increase in cytosolic calcium concentration. High levels of Ca2+ caused next the activation of RasGRF (Ras-specific guanine nucleotide releasing factor), which then induced via Ras UPR (unfolded protein response), that is, BiP (binding immunoglobulin protein), CHOP (CCAAT enhancer–binding protein homologous protein), and phosphorylation of eIF2α (eukaryotic initiation factor 2α)44 (Figure 2A). Another important player in the ER stress response is XBP1 (X-box-binding protein 1).53 However, while spliced XBP1 (XPB1s), which positively regulates UPR, contributes to EC apoptosis and atherosclerosis formation, the unspliced XBP1 (XBP1u) can induce the antioxidant response.54 Interestingly, disturbed flow elevated expression of antioxidant genes in ECs in XBP1u- and HDAC3 (histone deacetylase 3)-dependent manner. Increased expression of XBP1u and HDAC3 in HUVECs has decreased with KDR (kinase insert domain receptor) or PI3K (phosphatidylinositol-4,5-bisphosphate 3-kinase) inhibition. What is more, spliced XBP1 decreased HDAC3 levels, while overexpression of XBP1u protected it. Furthermore, high expression of XBP1u protected ECs from H2O2-induced oxidative stress. The latter effect was mediated by the increased stability of Nrf2 transcription factor and upregulation of its target—Hmox154 (Figure 2B).Download figureDownload PowerPointFigure 2. Endoplasmic reticulum (ER) stress leads to the activation of Nox4 on ER surface but not cell membrane and increases H2O2 levels. Increased oxidative stress inactivates sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), what causes the increase of cytoplasmatic Ca2+, activation of RasGRF, and Ras. Ras induces then unfolded protein response, namely BiP (binding immunoglobulin protein), CHOP (CCAAT enhancer–binding protein homologous protein), and phosphorylation of eIF2α (A). Disturbed flow causes ligand-independent activation of KDR, which induces formation of mTORC2-Akt1-XBP1u-HDAC3 complex and increases Akt1 phosphorylation, what contributes to the enhances stability of nuclear factor erythroid 2–related factor 2 (Nrf2). Nrf2, the regulator of antioxidant response, induces HMOX1 expression, which protects endothelial cells from oxidative stress (B).Laminar shear stress increases expression of transcription factor EB (TFEB) in cultured human ECs.55 TFEB is a basic helix–loop–helix transcription factor, which regulates lysosomal biogenesis.56 Laminar shear stress induced TFEB translocation to the nucleus and decreased mTOR (mechanistic target of rapamycin) activity in ECs. Interestingly, atherosclerosis-resistant regions of mouse aorta had higher TFEB levels than atherosclerosis-prone ones. TFEB overexpression reduced levels of H2O2 and superoxide, as well as expression of SELE, MCP1, VCAM1, IL1B, IL6, and IL8, in ECs and human coronary artery ECs. ECs overexpressing TFEB also had a higher expression of HMOX1, SOD2, and TXN1. Importantly, TFEB can bind to its putative binding sites in the HMOX1 promoter and SOD2 intron 2. However, knockdown only of HMOX1 in TFEB-overexpressing EC potently attenuated the anti-inflammatory effect of TFEB. Furthermore, although TFEB is known to regulate autophagy,56ATG5 silencing or pharmacological inhibition of autophagy did not block TFEB anti-inflammatory activity. mTie2-TFEB mice overexpressing TFEB in ECs showed less leukocyte rolling after lipopolysaccharide treatment than wild-type (WT) animals. Finally, Apoe−/−mTie2-TFEB mice on high cholesterol diet had less atherosclerotic lesions than Apoe−/− control animals.55Nrf2 in steady state conditions is sequestered by Keap1 and directed to the proteasomal degradation.57 Therefore, the regulation of Nrf2 activity is of potential clinical interest. Recent work by Xie et al58 showed that hydrogen sulfide could enhance Nrf2 activity in diabetic atherosclerotic mice and ECs treated with high glucose and oxidized low-density lipoproteins (LDLs). Streptozotocin-treated Ldlr−/− mice on a high-fat diet had less atherosclerotic lesions when treated with GYY4137—H2S donor. H2S treatment reduced ROS levels and VCAM1 and ICAM1 expressions and enhanced Nrf2 nuclear translocation in both diabetic atherosclerotic mice and ECs treated with high glucose and oxidized LDLs. H2S did not show the protective effect in Ldlr−/−Nfe2l2−/− mice or in ECs with silenced Nfe2l2. Interestingly, H2S enhanced Nrf2 activity by S-sulphydrylation of Keap1 at Cys151.58Interestingly, lysophosphatidylcholines (LPC)—proinflammatory lipids—can contribute to the ROS formation in atherosclerosis.59 The concentration of LPC, as well as expression of Pla2g7 and Pla2g4c, were higher in Apoe−/− aortas than in control ones. LPC quickly induced both mitochondrial ROS and to lesser levels cytoplasmatic ROS. Inhibition of NADPH oxidases further increased ROS levels. LPC increased cytoplasmatic and mitochondrial Ca2+, what was crucial for the induction of mitochondrial ROS production. LPC elevated mitochondrial proton leak but not ATP production and did not affect levels of mitochondrial superoxide dismutase or uncoupling protein 3. Furthermore, LPC increased expression of proatherogenic genes, such as ICAM1, IL6, and MMP2, what was attenuated by mitoTEMPO—mitochondrial ROS scavenger. Finally, mitoTEMPO inhibited LPC-induced monocyte adhesion to ECs in vitro, and leukocyte rolling and numbers of total and inflammatory monocytes in Apoe−/− high-fat diet mice.59Mitochondrial oxidative stress can be decreased by thioredoxin 2 (Txn2) that acts together with thioredoxin reductase 2 (Txnrd2) and peroxiredoxin 3 (Prdx3).60 Importantly, the endothelial-specific knockout of Txnrd2 impaired angiogenesis and arteriogenesis after femoral artery ligation and vascular function.61 Lack of Txnrd2 in ECs rendered them more proinflammatory and prothrombotic. Embryonic endothelial progenitor cells deficient in Txnrd2 showed higher intracellular ROS levels and more positive mitochondrial potential. Such cells had also decreased angiogenic properties in vitro, what could be reversed by Txnrd2 re-expression.61 Therefore, the imbalance of redox-mediated signaling and the consequence results in endothelial dysfunction that is a key event for the development of atherosclerosis.Smooth Muscle CellsFine-tuning of SMC proliferation and differentiation status is crucial for the development of atherosclerosis62 because they can contribute to the formation of neointima but, on the other hand, can stabilize the plaque and prevent its rupture.11,63 Oxidative stress in atherosclerosis results primarily from the activity of NAD(P)H oxidases.64 However, their role in SMCs, especially in the context of atherosclerosis, remains ambiguous. Mice lacking Nox1 developed less neointima in femoral arteries after the wire injury than control animals.65 On the other hand, SMC-specific overexpression of Nox1 did not enhance neoplasia formation. Nox1-deficient SMCs were further characterized by lower proliferation rate and migration than WT SMCs. Overexpression of Nox1 slightly enhanced both of the latter characteristics. Lower migration rate in Nox1-deficient cells was associated with changes in the regulation of actin cytoskeleton, that is, cofilin phosphorylation and mDia1 expression increased while PAK1 levels were lower.65 Furthermore, expression of Nox1 was higher in neointimal SMCs than in normal medial cells.66 Elevated levels of Nox1 were associated with ERK1/2 (extracellular signal-regulated kinases 1/2) activation and enhanced MMP-9 (matrix metallopeptidase 9).66Importantly, Nox1 forms canonical or hybrid systems with p47phox in place of NoxO1 in the hybrid system. Production of superoxide by hybrid Nox1 is regulated by ezrin–radixin–moesin-binding phosphoprotein 50 (EBP50).67 Expression of EBP50 is elevated in SMC after the angioplasty.68 EBP50 increased SMC proliferation with inhibiting antimitogenic parathyroid hormone type 1 receptor69 and regulation of p21cip1 and Skp2.70 Al Ghouleh et al67 recently showed that EBPO50−/− SMCs produce less superoxide than WT cells when treated with H2O2 or angiotensin II. In line with that, aortic rings from both EBPO50−/− or Nox1−/− mice show no increase in superoxide production after stimulation with angiotensin II. What is more, femoral arteries from EBPO50−/− mice had lower lipid peroxidation after lipopolysaccharide treatment than control animals. EBPO50 binds to the p47phox subunit of the hybrid Nox1 system and promotes Nox1 activity.67Expression of NADPH oxidases changes dynamically during the development of atherosclerosis.71 Nox1 levels were increased in aortas Apoe−/−Ldr−/− prior to the lesion formation and then normalized in later stages. Nox4 expression was elevated on later stages of atherosclerosis. SMCs isolated from mice with advanced atherosclerosis had lower Nox1 and higher Nox4 and p22phox levels and WT SMCs produced more superoxide or H2O2, but also expressed more catalase, SOD1 (superoxide dismuate 1), and SOD2. Furthermore, elevated Nox4 expression in SMCs increased their apoptosis in basal conditions and after stimulation with H2O2.71 Vendrov et al24 showed that while knockout of Ncf1 gene, encoding for p47phox, an essential regulatory subunit of both Nox1 and Nox2, is protective in young Apoe−/− mice, the effect is lost in aged animals.24 Areas of aortic atherosclerotic lesions, staining with DHE, levels of DNA oxidative damage, or macrophage infiltration were similar in aged Apoe−/− and Apoe−/−Ncf1−/− animals. What is more, SMCs from both types of aged mice showed similar upregulation of superoxide and H2O2 when treated with thrombin. Importantly, neither xanthine oxidation inhibition, nor lipoxygenase inhibition but Nox1/4 inhibitor attenuated ROS induction after stimulation with thrombin. The mitochondrial source of elevated ROS in aged SMCs was confirmed with the analysis of H2O2 levels in isolated mitochondria. Both SMC in aortas of aged animals or mitochondria in SMC from aged mice showed high staining against Nox4. When Nox4 was inhibited, levels of mitochondrial ROS in aged SMCs decreased. Interestingly, elevated levels of Nox4 were also detected in samples from older human donors. Last but not least, treatment with mitoTEMPO reduced thrombin-induced VCAM1 upregulation in SMCs in vitro, but also aortic wall stress and lesion area, and prevented oxidative damage in Apoe−/− mice.24SMC-specific expression of a human-dominant negative form of NOX4 (NOX4 P437H) resulted in decreased neointima formation after carotid artery denudation in FVB/N mice25 or lower atherosclerosis in Apoe−/− mice.72 Protective effect of dominant negative NOX4 in Apoe−/− mice was also associated with lower numbers of infiltrating macrophages. Overexpression of NOX4 P437H resulted in inhibition of soluble epoxide hydroxylase-2 expression and decreased proinflammatory signaling and levels of VCAM1, MCP1, and ICAM1, what was mirrored by lower macrophage adhesion.72 Importantly, soluble epoxide hydroxylase-2 downregulation reduced the expression of thrombospondin-1,72 which was crucial for the observed effects of NOX4 P437H on proliferation and migration in Apoe+/+ mice.25 On the other hand, Nox4 in Apoe−/− mice had a protective effect both in mice with spontaneous atherosclerosis development or after partial carotid artery ligation.26Nox4 deletion led to the decrease in H2O2 in mouse aortas, associated with the increase in superoxide levels. Microarray analysis of gene expression in WT or Nox4-deficient animals showed increased proinflammatory signaling in aortas from the Nox4-deficient mice.26Nox4 was protective also in diabetic Apoe−/− mice with streptozotocin-induced diabetes mellitus. Such mice had lower aortic expression of smooth muscle contractile markers, while levels of PDGF (platelet-derived growth factor), vimentin, and osteopontin increased.27Nox4 deletion further increased aortic expression of PDGF, collagen I, and Ki-67. SMCs isolated from Nox4-deficient animals had lower expression of smooth muscle contractile markers, produced less H2O2 but more superoxide and upregulated Nox1. Silencing of the latter gene resulted in the attenuation of PDGF-BB and osteopontin production and Ki-67 expression levels. Abnormal expression of PDGF-BB in Nox4−/− SMCs could also be reversed by PDGF inhibition or treatment with H2O2.27 What is more, Nox4 together with Nrf2 play significant roles in the CD38 signaling pathway, which is crucial for the maintenance of SMC contractile phenotype.45 Coronary arterial myocytes isolated from Cd38−/− mice had lower calponin and SM22α expression, accompanied by an increase in vimentin and PCNA (proliferating cell nuclear antigen). 7-Ketocholesterol, known atherogenic stimulus, further exacerbated the effect of Cd38 knockout. Lack of CD38 caused a decrease in Nrf2 expression and activity. Nfe2l2 silencing in coronary arterial myocytes enhanced reduction of contractile markers caused by 7-ketocholesterol. CD38 activity is crucial for the induction of Nox4 and superoxide production, which is then necessary for the Nrf2 translocation to the nucleus and maintenance of arterial myocytes contractile phenotype.45Interestingly, Nfe2l2 overexpression in human aortic SMCs resulted in an increase of GCLC, GCLM, and HMOX1 expression and decreased SMC proliferation.38 The latter effect could be partially reversed with tin protoporphyrin IX, which is an HMOX1 (heme oxygenase 1) inhibitor. Furthermore, Ad Nfe2l2 reduced oxidative stress, macrophage infiltration, and MCP-1 levels in balloon-injured aortas in rabbits. Finally, Nfe2l2 gene transfer in vivo decreased both SMC proliferation and apoptosis, and therefore, it had no effect on neointimal neoplasia.38 What is more, PDGF induces Nrf2 nuclear translocation and increases expression of its target genes: Nqo1, Hmox1, and Txnrd1.31Nfe2l2 silencing enhances PDGF-induced migration of SMCs. Furthermore, it leads to prolonged activation of Rac1, which can increase NADPH oxidase activity and ROS production. Nfe2l2 knockout also caused enhanced PDGF signaling, namely ERK1/2 phosphorylation, which can be inhibited with antioxidants, such as N-acetylcysteine. Femoral injury in Nfe2l2−/− mice resulted in decreased lumen area and higher neointima formation, with no significant changes in media and with greater ERK1/2 activation in neointima.31 Sulforaphane, which is Nrf2 activity inductor, reduces neointima formation in injured femoral arteries of mice fed a Western diet.39 In vitro, sulforaphane reduced leptin-induced SMC proliferation, cyclin D1 expression, and phosphorylation of both p70S6kinase and ribosomal S6 protein.39 Ashino and et al30 showed that injured femoral arteries contained regions of TUNEL+ (terminal deoxynucleotidyl transferase dUTP nick-end labeling) apoptotic cells that overlapped with regions rich in Nrf2high cells. Silencing of Keap1 in rat SMC resulted in higher Nrf2 levels and activity, resulted in higher caspase-3/7 activity, and increased apoptosis. Nfe2l2 silencing rescued the proapoptotic phenotype of Keap1-deficient cells. Finally, wire injury of femoral arteries in Nfe2l2−/− mice led to the enhanced formation of neointima, which contained less apoptotic cells. Therefore, authors proposed that Nrf2 protect from neointima also because of the enhancement of SMC apoptosis.30Interestingly, although Atg7−/− SMCs had higher Nrf2 activity, expression of its target genes, and resistance to oxidative stress, they showed accelerated senescence.73 The latter effect was related to the defective autophagy and accumulation of Sqstm1/p62, which is a Nrf2 target, but also contributes to its activation.74 In vivo, deletion of Atg7 in SMCs caused enhanced senescence and promoted neointima formation.73 On the other hand, carotid artery ligation in Sqsmt1−/− mice caused more neointima formation.75 SMCs isolated from Sqstm1−/− aortas proliferated and migrated faster.75 Overexpression of HMOX1, enzyme degrading toxic heme to biliverdin, carbon monoxide and ferrous iron, and target of Nrf2 activity in SMCs decreased their migration in response to PDGF-BB.76 Inhibitory effect of heme oxygenase-1 depended on its enzymatic activity and was mimicked by carbon monoxide. Increased activity of heme oxygenase-1 led to the upregulation of both VEGFA (vascular endothelial growth factor A) and VEGFR1 (vascular endothelial growth factor receptor 1). The latter one formed a complex with PDGFRβ, which attenuated PDGFRβ signaling.76 Activation of another Nrf2 target—NAD(P)H: quinone oxidoreductase-1—by β-lapochone reduced neointima formation after balloon injury in rat carotid arteries and inhibited PDGF-induced SMC proliferation. Increased NQO1 (4-nitroquinoline 1-oxide) activity caused AMPK activation mediated by LKB1 but not CaMKKβ (Ca2+/calmodulin-dependent protein kinase kinase beta).77 Taken together, Nrf2 is a crucial player in maintaining the hemostasis of the vessel wall via influencing inflammatory response, SMC proliferation, and neointimal formation.Increased SMC apoptosis may lead to the plaque instability and rupture.78 Wnt/β-catenin/WISP-1 (WNT1-inducible-signaling pathway protein 1) represents example of the pathway that can protect SMCs from apoptosis79 and oxidative stress but, on the other hand, enhance SMC migration and contribute to intimal thickening.80 Mill et al79 showed recently that macrophage-derived Wnt5a could protect SMC from H2O2-induced apoptosis. Exogenous Wnt5a increased amounts of active and nuclear β-catenin in SMC and induced TCF (transcription factor) signaling. However, TCF pathway was attenuated when cells were costimulated with H2O2, but this effect was dependent on the active β-catenin. Protective activity of Wnt5a against H2O2-induced activity was lost after LRP5/6 silencing, which suggests that it is regulated by Wnt/Frizzled/LRP5/6 pathway. Importantly, Wnt5a induced cytoprotective WISP-1 in CREB-dependent manner. Interestingly, SMC in stable plaques in human coronary arteries showed higher staining for WISP-1 than those in unstable plaques.79 Wnt2 also induced WISP-1 expression in SMC in β-catenin-dependent manner.80 Levels of Wnt2 and WISP-1 were elevated in ligated carotid arteries. Furthermore, WISP-1 overexpression promoted intimal thickening, which was reduced in Wnt2+/− animals.80Finally, although high glutathione levels and, that is, high ratio of reduced to oxidized glutathione are considered protective, too much of it can also lead to the enhanced vascular remodeling. Network analysis of gene expression in human carotid neointima showed that the most significantly downregulated network was the one with GPX1 in its hub.81 Furthermore, Apoe−/− mice with deleted Gpx1 were characterized with increased atherosclerotic plaque, which contained more SMCs but not macrophages. However, increased macrophage infiltration in Gpx1−/−Apoe−/− was previously reported by Torzewski et al.41 Furthermore, balloon angioplasty and stenting in Gpx1+/+Apoe−/− mice decreased Gpx1 expression. Global knockout of Gpx1 in Apoe−/− mice caused an increase in superoxide levels in media but not adventitia or endothelium. Effect of lack of Gpx1 on SMCs was mediated by the high activity of ROS1 receptor tyrosine kinase. Inhibition of tyrosine kinase activity or ROS1 silencing could decrease enhanced proliferation and migration of Gpx1−/−Apoe−/− SMCs. Gpx1−/− SMCs contained more glutathione, which resulted from its higher synthesis. Elevated levels of glutathione caused reductive stress that contributed to S-glutathionylation and inactivation of SHP-2 (tyrosine-protein phosphatase nonreceptor type 11) phosphatase, what then inhibited ROS1 inactivation81 (Figure 3). Interestingly, Izawa et al82 reported that buthionine sulfoximine, which is glutathione inhibitor, elevated vessel wall superoxide levels, but on the other hand decreased angiotensin II–induced vessel remodeling.Download figureDownload PowerPointFigure 3. Reductive stress contributes to ROS1 activation. Vascular injury leads to the downregulation of Gpx1, what is accompanied with elevated GSH synthesis. The increase of cellular GSH leads to S-glutathionylation of SHP-2 phosphatase, what in turn inhibits its activity and leads to prolonged activation of ROS1 receptor tyrosine kinase. ROS1 activity contributes t
What problem does this paper attempt to address?
-
Nadph Oxidase Activation Played A Critical Role in the Oxidative Stress Process in Stable Coronary Artery Disease
Jiefang Zhang,Meihui Wang,Zhengwei Li,Xukun Bi,Jiale Song,Shaoxiang Weng,Guosheng Fu
2016-01-01
American journal of translational research
Abstract:Objectives: The study was designed to investigate the oxidative stress levels of endothelial progenitor cells (EPCs) in stable coronary artery disease (CAD) and to explore the underlying mechanisms of NADPH oxidase activation and subsequent EPCs dysfunction. Methods: EPCs were isolated from patients with stable CAD (n=50) and matched healthy volunteers (n=50). NADPH oxidase activation was detected by measuring the expression of each subunit using western blotting and qPCR analyses and the membrane translocation of p47(phox) using immunofluorescence. The in vivo angiogenesis capacity was evaluated using immunofluorescence by transplanting EPCs into a rat hind limb ischemia model. The PKC inhibitor GO-6983 was used to determine the role of PKC in NADPH oxidase activation. Results: Oxidative stress level was increased and the in vivo angiogenesis capacity was impaired in EPCs obtained from CAD subjects with the activation of NADPH oxidase. P47(phox) membrane translocation increased in CAD group vs controls. These effects were resolved by NADPH oxidase inhibition. Up-regulation of PKC alpha/beta 2 was found in EPCs from CAD subjects, PKC inhibition GO-6983 could reduce the expression and activity of NADPH oxidation. Conclusions: NADPH oxidase activation via p47(phox) membrane translocation played a critical role in the initiation and progression of CAD, and the PKC alpha/beta 2 signaling pathway might be involved.
-
Endothelial AIP1 Regulates Vascular Remodeling by Suppressing NADPH Oxidase-2
Jiqin Zhang,Chaofei Chen,Li,Huanjiao J. Zhou,Fenghe Li,Haifeng Zhang,Luyang Yu,Yuxin Chen,Wang Min
DOI: https://doi.org/10.3389/fphys.2018.00396
IF: 4
2018-01-01
Frontiers in Physiology
Abstract:Objective: AIP1 expression is downregulated in human atherosclerotic plaques and global deletion of AIP1 in mice exacerbates atherosclerosis in ApoE-KO mouse models. However, the direct role of AIP1 in endothelium, vascular remodeling and associated vascular diseases has not been determined. Approach and Results: We used endothelial cell (EC)-specific AIP1-deficient (AIP1-ECKO) mice to define the role of AIP1 in vascular remodeling and intimamedia thickening in a mouse carotid artery ligation model characterized by both neointimal hyperplasia and inward vessel remodeling. Compared to WT littermates, AIP1-ECKO mice had 2.2-fold larger intima area and 4.4-fold thicker intima as measured by intima/media ratio in arteries with more proliferating vascular smooth muscle cells (VSMCs) at week 2-4 post-injury. Increased reactive oxygen species (ROS) in endothelium at early time points induced inflammation and vessel dysfunction in AIP1-ECKO prior to VSMC accumulations. Moreover, knockdown of AIP1 in human EC enhanced ROS generation which was attenuated by co-silencing of NOX2. Mechanistically, AIP1 via its proline-rich region binds to the SH3 domain of cytosolic subunit p47phox to disrupt formation of an active NOX2 complex, attenuating ROS production. Conclusion: Our study supports that AIP1 regulates vascular remodeling with intimamedia thickening by suppressing endothelial NOX2-dependent oxidative stress. Highlights: In a carotid ligation model, endothelial cell (EC)-specific AIP1-deficient (AIP1-ECKO) mice had much larger media area, thicker vessel wall and augmented neointima formation. Increased production of reactive oxygen species in vascular EC at early time points concomitant with vessel dysfunction in AIP1-ECKO. AIP1 via its proline-rich region binds to the SH3 domain of cytosolic subunit p47phox to disrupt formation of an active NOX2 complex, attenuating ROS production.
-
Reactive Oxygen Species (ROS), Intimal Thickening, and Subclinical Atherosclerotic Disease
Denise Burtenshaw,Michael Kitching,Eileen M Redmond,Ian L Megson,Paul A Cahill
DOI: https://doi.org/10.3389/fcvm.2019.00089
2019-08-02
Abstract:Arteriosclerosis causes significant morbidity and mortality worldwide. Central to this process is the development of subclinical non-atherosclerotic intimal lesions before the appearance of pathologic intimal thickening and advanced atherosclerotic plaques. Intimal thickening is associated with several risk factors, including oxidative stress due to reactive oxygen species (ROS), inflammatory cytokines and lipid. The main ROS producing systems in-vivo are reduced nicotinamide dinucleotide phosphate (NADPH) oxidase (NOX). ROS effects are context specific. Exogenous ROS induces apoptosis and senescence, whereas intracellular ROS promotes stem cell differentiation, proliferation, and migration. Lineage tracing studies using murine models of subclinical atherosclerosis have revealed the contributory role of medial smooth muscle cells (SMCs), resident vascular stem cells, circulating bone-marrow progenitors and endothelial cells that undergo endothelial-mesenchymal-transition (EndMT). This review will address the putative physiological and patho-physiological roles of ROS in controlling vascular cell fate and ROS contribution to vascular regeneration and disease progression.
-
The Role of Oxidative Stress in Atherosclerosis
Matthew Batty,Emma Yu,Martin R. Bennett
DOI: https://doi.org/10.3390/cells11233843
IF: 6
2022-12-01
Cells
Abstract:Atherosclerosis is a chronic inflammatory disease of the vascular system and is the leading cause of cardiovascular diseases worldwide. Excessive generation of reactive oxygen species (ROS) leads to a state of oxidative stress which is a major risk factor for the development and progression of atherosclerosis. ROS are important for maintaining vascular health through their potent signalling properties. However, ROS also activate pro-atherogenic processes such as inflammation, endothelial dysfunction and altered lipid metabolism. As such, considerable efforts have been made to identify and characterise sources of oxidative stress in blood vessels. Major enzymatic sources of vascular ROS include NADPH oxidases, xanthine oxidase, nitric oxide synthases and mitochondrial electron transport chains. The production of ROS is balanced by ROS-scavenging antioxidant systems which may become dysfunctional in disease, contributing to oxidative stress. Changes in the expression and function of ROS sources and antioxidants have been observed in human atherosclerosis while in vitro and in vivo animal models have provided mechanistic insight into their functions. There is considerable interest in utilising antioxidant molecules to balance vascular oxidative stress, yet clinical trials are yet to demonstrate any atheroprotective effects of these molecules. Here we will review the contribution of ROS and oxidative stress to atherosclerosis and will discuss potential strategies to ameliorate these aspects of the disease.
cell biology
-
Oxidative Stress in Atherosclerosis
Ajoe John Kattoor,Naga Venkata K Pothineni,Deepak Palagiri,Jawahar L. Mehta
DOI: https://doi.org/10.1007/s11883-017-0678-6
IF: 5.967
2017-09-18
Current Atherosclerosis Reports
Abstract:Purpose of ReviewAtherosclerosis is now considered a chronic inflammatory disease. Oxidative stress induced by generation of excess reactive oxygen species has emerged as a critical, final common mechanism in atherosclerosis. Reactive oxygen species (ROS) are a group of small reactive molecules that play critical roles in the regulation of various cell functions and biological processes. Although essential for vascular homeostasis, uncontrolled production of ROS is implicated in vascular injury. Endogenous anti-oxidants function as checkpoints to avoid these untoward consequences of ROS, and an imbalance in the oxidant/anti-oxidant mechanisms leads to a state of oxidative stress. In this review, we discuss the role of ROS and anti-oxidant mechanisms in the development and progression of atherosclerosis, the role of oxidized low-density lipoprotein cholesterol, and highlight potential anti-oxidant therapeutic strategies relevant to atherosclerosis.Recent FindingsThere is growing evidence on how traditional risk factors translate into oxidative stress and contribute to atherosclerosis. Clinical trials evaluating anti-oxidant supplements had failed to improve atherosclerosis. Current studies focus on newer ROS scavengers that specifically target mitochondrial ROS, newer nanotechnology-based drug delivery systems, gene therapies, and anti-miRNAs. Synthetic LOX-1 modulators that inhibit the effects of Ox-LDL are currently in development.SummaryResearch over the past few decades has led to identification of multiple ROS generating systems that could potentially be modulated in atherosclerosis. Therapeutic approaches currently being used for atheroslcerotic vascular disease such as aspirin, statins, and renin-angiotensin system inhibitors exert a pleiotropic antioxidative effects. There is ongoing research to identify novel therapeutic modalities to selectively target oxidative stress in atherosclerosis.
peripheral vascular disease
-
NOXA1-dependent NADPH oxidase regulates redox signaling and phenotype of vascular smooth muscle cell during atherogenesis
Aleksandr E Vendrov,Arihiro Sumida,Chandrika Canugovi,Andrey Lozhkin,Takayuki Hayami,Nageswara R Madamanchi,Marschall S Runge
DOI: https://doi.org/10.1016/j.redox.2018.11.021
Abstract:Increased reactive oxygen species (ROS) production and inflammation are key factors in the pathogenesis of atherosclerosis. We previously reported that NOX activator 1 (NOXA1) is the critical functional homolog of p67phox for NADPH oxidase activation in mouse vascular smooth muscle cells (VSMC). Here we investigated the effects of systemic and SMC-specific deletion of Noxa1 on VSMC phenotype during atherogenesis in mice. Neointimal hyperplasia following endovascular injury was lower in Noxa1-deficient mice versus the wild-type following endovascular injury. Noxa1 deletion in Apoe-/- or Ldlr-/- mice fed a Western diet showed 50% reduction in vascular ROS and 30% reduction in aortic atherosclerotic lesion area and aortic sinus lesion volume (P < 0.01). SMC-specific deletion of Noxa1 in Apoe-/- mice (Noxa1SMC-/-/Apoe-/-) similarly decreased vascular ROS levels and atherosclerotic lesion size. TNFα-induced ROS generation, proliferation and migration were significantly attenuated in Noxa1-deficient versus wild-type VSMC. Immunofluorescence analysis of atherosclerotic lesions showed a significant decrease in cells positive for CD68 and myosin11 (22% versus 9%) and Mac3 and α-actin (17% versus 5%) in the Noxa1SMC-/-/Apoe-/- versus Apoe-/- mice. The expression of transcription factor KLF4, a modulator of VSMC phenotype, and its downstream targets - VCAM1, CCL2, and MMP2 - were significantly reduced in the lesions of Noxa1SMC-/-/Apoe-/- versus Apoe-/- mice as well as in oxidized phospholipids treated Noxa1SMC-/- versus wild-type VSMC. Our data support an important role for NOXA1-dependent NADPH oxidase activity in VSMC plasticity during restenosis and atherosclerosis, augmenting VSMC proliferation and migration and KLF4-mediated transition to macrophage-like cells, plaque inflammation, and expansion.
-
Oxidative stress disrupts vascular microenvironmental homeostasis affecting the development of atherosclerosis
Ruifei Shao,Rui Chen,Qiang Zheng,Mengyu Yao,Kunlin Li,Yu Cao,Lihong Jiang
DOI: https://doi.org/10.1002/cbin.12239
IF: 4.473
2024-10-07
Cell Biology International
Abstract:Atherosclerosis is primarily an inflammatory reaction of the cardiovascular system caused by endothelial damage, leading to progressive thickening and hardening of the vessel walls, as well as extensive necrosis and fibrosis of the surrounding tissues, the most necessary pathological process causing cardiovascular disease. When the body responds to harmful internal and external stimuli, excess oxygen free radicals are produced causing oxidative stress to occur in cells and tissues. Simultaneously, the activation of inflammatory immunological processes is followed by an elevation in oxygen free radicals, which directly initiates the release of cytokines and chemokines, resulting in a detrimental cycle of vascular homeostasis abnormalities. Oxidative stress contributes to the harm inflicted upon vascular endothelial cells and the decrease in nitric oxide levels. Nitric oxide is crucial for maintaining vascular homeostasis and is implicated in the development of atherosclerosis. This study examines the influence of oxidative stress on the formation of atherosclerosis, which is facilitated by the vascular milieu. It also provides an overview of the pertinent targets and pharmaceutical approaches for treating this condition.
cell biology
-
The effects of oxidative stress on the development of atherosclerosis
Mohsen Khosravi,Adeleh Poursaleh,Ghasem Ghasempour,Shaikhnia Farhad,Mohammad Najafi
DOI: https://doi.org/10.1515/hsz-2018-0397
2019-04-09
Biological Chemistry
Abstract:Abstract Atherosclerosis is a cardiovascular disease (CVD) known widely world wide. Several hypothesizes are suggested to be involved in the narrowing of arteries during process of atherogenesis. The oxidative modification hypothesis is related to oxidative and anti-oxidative imbalance and is the most investigated. The aim of this study was to review the role of oxidative stress in atherosclerosis. Furthermore, it describes the roles of oxidative/anti-oxidative enzymes and compounds in the macromolecular and lipoprotein modifications and in triggering inflammatory events. The reactive oxygen (ROS) and reactive nitrogen species (RNS) are the most important endogenous sources produced by non-enzymatic and enzymatic [myeloperoxidase (MPO), nicotinamide adenine dinucleotide phosphate (NADH) oxidase and lipoxygenase (LO)] reactions that may be balanced with anti-oxidative compounds [glutathione (GSH), polyphenols and vitamins] and enzymes [glutathione peroxidase (Gpx), peroxiredoxins (Prdx), superoxide dismutase (SOD) and paraoxonase (PON)]. However, the oxidative and anti-oxidative imbalance causes the involvement of cellular proliferation and migration signaling pathways and macrophage polarization leads to the formation of atherogenic plaques. On the other hand, the immune occurrences and the changes in extra cellular matrix remodeling can develop atherosclerosis process.
biochemistry & molecular biology
-
Oxidative stress, AGE, and atherosclerosis
E Schleicher,U Friess
DOI: https://doi.org/10.1038/sj.ki.5002382
Abstract:Numerous reports on the molecular mechanism of atherogenesis indicate an increase in oxidative stress, formation of advanced glycoxidation end products (AGEs), chronic inflammation, and activated cellular response particularly in diabetic patients. To elucidate the initiating and early accelerating events this review will focus on the molecular causes of the induction of these stress factors, their interactions, and their contribution to atherogenesis. Metabolic factors such as elevated free fatty acids, high glucose levels or AGEs induce reactive oxygen species (ROS) in vascular cells leading to ongoing AGE formation and to gene induction of proinflammatory cytokines. Vice versa, numerous cytokines found elevated in obesity and diabetes may also induce oxidative stress thus a circulus vitious may be initiated and accelerated. Increased production of ROS, mainly from mitochondria and NAD(P)H oxidase, stimulates signaling cascades including protein kinase C and mitogen-activated protein kinase pathway leading to nuclear translocation of transcription factors such as nuclear factor-kappaB (NF-kappaB), activator protein 1, and specificity protein 1. Subsequently, the expression of numerous genes including cytokines is rapidly induced, which, in turn, may act on vascular cells promoting the deleterious effects. From animal models of accelerated atherosclerosis a causal role of NAD(P)H oxidase and the AGE/RAGE/NF-kappaB axis to atherogenesis is suggested. Because all factors involved form a highly interwoven network of interactions, the blockade of ROS or AGE formation at different sites may interrupt the vicious cycle. Promising candidate agents are, currently on trial. Most important to clinical practice, a number of drugs commonly used in the treatment of diabetes, hypertension, or cardiovascular disease, such as angiotensin-converting enzyme inhibitors, AT(1) receptor blockers, 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (statins), and thiazolidindiones have shown promising 'preventive' intracellular antioxidant activity in addition to their primary pharmacological actions.
-
Endothelial Cell Superoxide Generation: Regulation and Relevance for Cardiovascular Pathophysiology.
JM Li,AM Shah
DOI: https://doi.org/10.1152/ajpregu.00124.2004
2004-01-01
AJP Regulatory Integrative and Comparative Physiology
Abstract:The endothelial generation of reactive oxygen species (ROS) is important both physiologically and in the pathogenesis of many cardiovascular disorders. ROS generated by endothelial cells include superoxide (O2-*), hydrogen peroxide (H2O2), peroxynitrite (ONOO-*), nitric oxide (NO), and hydroxyl (*OH) radicals. The O2-* radical, the focus of the current review, may have several effects either directly or through the generation of other radicals, e.g., H2O2 and ONOO-*. These effects include 1) rapid inactivation of the potent signaling molecule and endothelium-derived relaxing factor NO, leading to endothelial dysfunction; 2) the mediation of signal transduction leading to altered gene transcription and protein and enzyme activities ("redox signaling"); and 3) oxidative damage. Multiple enzymes can generate O2-*, notably xanthine oxidase, uncoupled NO synthase, and mitochondria. Recent studies indicate that a major source of endothelial O2-* involved in redox signaling is a multicomponent phagocyte-type NADPH oxidase that is subject to specific regulation by stimuli such as oscillatory shear stress, hypoxia, angiotensin II, growth factors, cytokines, and hyperlipidemia. Depending on the level of oxidants generated and the relative balance between pro- and antioxidant pathways, ROS may be involved in cell growth, hypertrophy, apoptosis, endothelial activation, and adhesivity, for example, in diabetes, hypertension, atherosclerosis, heart failure, and ischemia-reperfusion. This article reviews our current knowledge regarding the sources of endothelial ROS generation, their regulation, their involvement in redox signaling, and the relevance of enhanced ROS generation and redox signaling to the pathophysiology of cardiovascular disorders where endothelial activation and dysfunction are implicated.
-
ROS-Induced Endothelial Dysfunction in the Pathogenesis of Atherosclerosis
Ruiyi Yan,Xiao Zhang,Wenlong Xu,Jiayao Li,Yixin Sun,Shengyan Cui,Ran Xu,Wenjing Li,Liqun Jiao,Tao Wang
DOI: https://doi.org/10.14336/ad.2024.0309
2024-01-01
Aging and Disease
Abstract:Various signaling pathways are regulated by reactive oxygen species (ROS), which are radical oxygen intermediates under normal physiological conditions. However, when the buffering capacity of antioxidant enzymes is exceeded by the accumulation of ROS, oxidative stress, and endothelial cell dysfunction occur, which have been recognized as key contributors to the development of atherosclerosis. In this review, an overview is provided on mechanisms underlying ROS generation in endothelial cells and the involved regulatory pathways. Further, we discuss the ROS induced endothelial cell dysfunction and its relationship with atherosclerosis. Current knowledge on ROS-induced endothelial impairment is presented, characterized by decreased NO bioavailability, intracellular dysfunction and ox-LDL accumulation. Furthermore, biomarkers such as oxidative products of lipid, protein, and nucleotide are discussed as measurements for ROS levels. Novel interventions targeting oxidative stress are listed as potential pharmacotherapies in clinical practice. In conclusion, this review presents a systematic analysis of the mechanisms underlying ROS generation and elucidates how manipulation of these mechanisms can safeguard endothelial cell function.
geriatrics & gerontology,gerontology
-
Effect of reactive oxygen, nitrogen, and sulfur species on signaling pathways in atherosclerosis
Kundan Solanki,Evgeny Bezsonov,Alexander Orekhov,Suraj P. Parihar,Shivani Vaja,Fletcher A. White,Alexander G. Obukhov,Mirza S. Baig
DOI: https://doi.org/10.1016/j.vph.2024.107282
IF: 5.738
2024-02-07
Vascular Pharmacology
Abstract:Atherosclerosis is a chronic inflammatory disease in which fats, lipids, cholesterol, calcium, proliferating smooth muscle cells, and immune cells accumulate in the intima of the large arteries, forming atherosclerotic plaques. A complex interplay of various vascular and immune cells takes place during the initiation and progression of atherosclerosis. Multiple reports indicate that tight control of reactive oxygen species (ROS), reactive nitrogen species (RNS), and reactive sulfur species (RSS) production is critical for maintaining vascular health. Unrestricted ROS and RNS generation may lead to activation of various inflammatory signaling pathways, facilitating atherosclerosis. Given these deleterious consequences, it is important to understand how ROS and RNS affect the signaling processes involved in atherogenesis. Conversely, RSS appears to exhibit an atheroprotective potential and can alleviate the deleterious effects of ROS and RNS. Herein, we review the literature describing the effects of ROS, RNS, and RSS on vascular smooth muscle cells, endothelial cells, and macrophages and focus on how changes in their production affect the initiation and progression of atherosclerosis. This review also discusses the contribution of ROS, RNS, and RSS in mediating various post-translational modifications, such as oxidation, nitrosylation, and sulfation, of the molecules involved in inflammatory signaling.
pharmacology & pharmacy
-
Dynamic determination of Ox-LDL-induced oxidative/nitrosative stress in single macrophage by using fluorescent probes.
Tongle Deng,Kedi Xu,Le Zhang,Xiaoxiang Zheng
DOI: https://doi.org/10.1016/j.cellbi.2008.08.013
IF: 4.473
2008-01-01
Cell Biology International
Abstract:Increased oxidative/nitrosative stress, resulting from generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) appears to play an important role in the inflammatory responses to atherosclerosis. By using MitoTracker Orange CM-H2TMRos, CM-H2DCFDA (DCF-DA), Dihydrorhodamine 123 (DHR123), DAF-FM, Dihydroethidium (DHE) and JC-1 alone or in all combinations of red and green probes, the present study was designed to monitor the ROS and RNS generation in acute exposure of single monocyte U937-derived macrophage to oxidized low density lipoprotein (Ox-LDL). Acute Ox-LDL (100μg/ml) treatment increased time-dependently production of intracellular nitric oxide (NO), superoxide (O2−), hydrogen peroxide (H2O2) and peroxynitrite (ONOO−), and decreased mitochondrial membrane potential (Δψ) in single cell. Pretreatment of aminoguanidine (an inhibitor of inducible nitric oxide synthase (iNOS), 10μM) and vitamin C (an antioxidant agent, 100μM) for 2h, reduced significantly the Ox-LDL-induced increase of NO and O2−, and vitamin C completely inhibited increase of intracellular NO and O2−. In contrast to aminoguanidine, Vitamin C pretreatment significantly prevented Ox-LDL-induced overproduction of NO and O2− (P<0.01), indicating that antioxidant may be more effective in therapeutic application than iNOS inhibitor in dysfunction of ROS/RNS. By demonstrating a complex imbalance of ROS/RNS via fluorescent probes in acute exposure of single cell to Ox-LDL, oxidative/nitrosative stress might be more detected in the early atherosclerotic lesions.
-
Oxidative Stress and Antioxidants in Atherosclerosis Development and Treatment
Anastasia V. Poznyak,Andrey V. Grechko,Varvara A. Orekhova,Yegor S. Chegodaev,Wei-Kai Wu,Alexander N. Orekhov
DOI: https://doi.org/10.3390/biology9030060
2020-03-21
Biology
Abstract:Atherosclerosis can be regarded as chronic inflammatory disease affecting the arterial wall. Despite the recent progress in studying the pathogenesis of atherosclerosis, some of the pathogenic mechanisms remain to be fully understood. Among these mechanisms is oxidative stress, which is closely linked to foam cells formation and other key events in atherosclerosis development. Two groups of enzymes are involved in the emergence of oxidative stress: Pro-oxidant (including NADPH oxidases, xanthine oxidases, and endothelial nitric oxide synthase) and antioxidant (such as superoxide dismutase, catalases, and thioredoxins). Pro-oxidant enzymes in normal conditions produce moderate concentrations of reactive oxidant species that play an important role in cell functioning and can be fully utilized by antioxidant enzymes. Under pathological conditions, activities of both pro-oxidant and antioxidant enzymes can be modified by numerous factors that can be relevant for developing novel therapies. Recent studies have explored potential therapeutic properties of antioxidant molecules that are capable to eliminate oxidative damage. However, the results of these studies remain controversial. Other perspective approach is to inhibit the activity of pro-oxidant enzymes and thus to slow down the progression of atherosclerosis. In this review we summarized the current knowledge on oxidative stress in atherosclerosis and potential antioxidant approaches. We discuss several important antioxidant molecules of plant origin that appear to be promising for treatment of atherosclerosis.
biology
-
Heme oxygenase-1, oxidation, inflammation, and atherosclerosis
Jesus A Araujo,Min Zhang,Fen Yin
DOI: https://doi.org/10.3389/fphar.2012.00119
2012-07-19
Abstract:Atherosclerosis is an inflammatory process of the vascular wall characterized by the infiltration of lipids and inflammatory cells. Oxidative modifications of infiltrating low-density lipoproteins and induction of oxidative stress play a major role in lipid retention in the vascular wall, uptake by macrophages and generation of foam cells, a hallmark of this disorder. The vasculature has a plethora of protective resources against oxidation and inflammation, many of them regulated by the Nrf2 transcription factor. Heme oxygenase-1 (HO-1) is a Nrf2-regulated gene that plays a critical role in the prevention of vascular inflammation. It is the inducible isoform of HO, responsible for the oxidative cleavage of heme groups leading to the generation of biliverdin, carbon monoxide, and release of ferrous iron. HO-1 has important antioxidant, antiinflammatory, antiapoptotic, antiproliferative, and immunomodulatory effects in vascular cells, most of which play a significant role in the protection against atherogenesis. HO-1 may also be an important feature in macrophage differentiation and polarization to certain subtypes. The biological effects of HO-1 are largely attributable to its enzymatic activity, which can be conceived as a system with three arms of action, corresponding to its three enzymatic byproducts. HO-1 mediated vascular protection may be due to a combination of systemic and vascular local effects. It is usually expressed at low levels but can be highly upregulated in the presence of several proatherogenic stimuli. The HO-1 system is amenable for use in the development of new therapies, some of them currently under experimental and clinical trials. Interestingly, in contrast to the HO-1 antiatherogenic actions, the expression of its transcriptional regulator Nrf2 leads to proatherogenic effects instead. This suggests that a potential intervention on HO-1 or its byproducts may need to take into account any potential alteration in the status of Nrf2 activation. This article reviews the available evidence that supports the antiatherogenic role of HO-1 as well as the potential pathways and mechanisms mediating vascular protection.
-
The Protein S-nitrosylation of Splicing and Translational Machinery in Vascular Endothelial Cells is Susceptible to Oxidative Stress Induced by Oxidized Low-Density Lipoprotein.
Xiaohui Xu,Hongyan Qiu,Feng Shi,Zhe Wang,Xiaowei Wang,Lan Jin,Lianli Chi,Qunye Zhang
DOI: https://doi.org/10.1016/j.jprot.2019.01.001
IF: 3.855
2019-01-01
Journal of Proteomics
Abstract:Oxidized low-density lipoprotein (ox-LDL) can impair endothelial function and lead to the atherosclerosis development. Protein S-nitrosylation is sensitive to cellular redox state and acts as a crucial regulator and executor of nitric oxide (NO) signaling pathways. Aberrant S-nitrosylation contributes to the pathogenesis of cardiovascular and cerebrovascular diseases. However, the effect of ox-LDL on S-nitrosylation and its significance for endothelial dysfunction have not been studied at proteome level. Herein, the combined quantitative analysis of proteome and S-nitrosoproteome was performed using an integrated biotin switch and iTRAQ labeling approach in EA.hy926 cell line derived from human umbilical vein endothelial cell (HUVEC) treated with ox-LDL. A total of 2204 S-nitrosylated (SNO) peptides of 1318 SNO-proteins were quantified. Notably, 352 SNO-peptides of 262 SNO-proteins were significantly regulated after excluding S-nitrosylation changes caused by protein expression alterations. Many of them belonged to mRNA splicing, ribosomal structure and translational regulatory proteins, covering the entire translation process. The results indicated that S-nitrosylation of the splicing and translational machinery in vascular endothelial cells was susceptible to ox-LDL. Abnormal protein S-nitrosylation may be one pivotal mechanism underlying endothelial dysfunction induced by ox-LDL. This study potentially enriches the present understanding of pro-atherogenic effect of ox-LDL from the perspective of S-nitrosylation. SIGNIFICANCE: The role of ox-LDL in endothelial dysfunction and atherosclerosis development has been recognized from the aspect of impaired NO production. However, its effect on S-nitrosylation, which is directly related to NO signaling pathway, still remains largely unexplored. Our work initially provided a systematic characterization of S-nitrosoproteome in ox-LDL-treated endothelial cells after ruling out the changes of S-nitrosylation modification caused by protein expression alone. MS-based approach coupled with iTRAQ technique indicated 262 SNO-proteins were significantly regulated. Functional enrichment and interaction network analysis revealed that proteins involved in mRNA splicing and translational machinery were susceptible to abnormal S-nitrosylation under ox-LDL treatment. This achievement suggested one potential mechanism underlying endothelial dysfunction induced by ox-LDL from the perspective of S-nitrosoproteome.
-
Reactive Oxygen Species: Key Regulators In Vascular Health And Diseases
Qishan Chen,Qiwen Wang,Jianhua Zhu,Qingzhong Xiao,Li Zhang
DOI: https://doi.org/10.1111/bph.13828
IF: 7.3
2018-01-01
British Journal of Pharmacology
Abstract:ROS are a group of small reactive molecules that play critical roles in the regulation of various cell functions and biological processes. In the vascular system, physiological levels of ROS are essential for normal vascular functions including endothelial homeostasis and smooth muscle cell contraction. In contrast, uncontrolled overproduction of ROS resulting from an imbalance of ROS generation and elimination leads to the development of vascular diseases. Excessive ROS cause vascular cell damage, the recruitment of inflammatory cells, lipid peroxidation, activation of metalloproteinases and deposition of extracellular matrix, collectively leading to vascular remodelling. Evidence from a large number of studies has revealed that ROS and oxidative stress are involved in the initiation and progression of numerous vascular diseases including hypertension, atherosclerosis, restenosis and abdominal aortic aneurysm. Furthermore, considerable research has been implemented to explore antioxidants that can reduce ROS production and oxidative stress in order to ameliorate vascular diseases. In this review, we will discuss the nature and sources of ROS, their roles in vascular homeostasis and specific vascular diseases and various antioxidants as well as some of the pharmacological agents that are capable of reducing ROS and oxidative stress. The aim of this review is to provide information for developing promising clinical strategies targeting ROS to decrease cardiovascular risks.Linked ArticlesThis article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc
-
NADPH Oxidase P47phox Sirna Attenuates Adventitial Fibroblasts Proliferation and Migration in Apoe(-/-) Mouse.
Fang Xu,Ying Liu,Lei Shi,Wei Liu,Li Zhang,Hongjing Cai,Jie Qi,Yong Cui,Weichen Wang,Yejia Hu
DOI: https://doi.org/10.1186/s12967-015-0407-2
IF: 8.44
2015-01-01
Journal of Translational Medicine
Abstract:BACKGROUND:Reactive oxide species (ROS) derived from NADPH oxidases is involved in atherosclerosis. However, as a key component of NADPH oxidase, how p47phox regulates NADPH oxidases activity, ROS production and adventitial fibroblasts (AFs) function remains unclear.METHODS:p47phox in aortic arteries of apoE(-/-) mice fed with hyperlipid diet was detected by immunohistochemistry. NADPH oxidase activity, superoxide anion (O2(-)) generation and p47phox expression were analyzed in primary AFs treated by diphenyleneiodonium (DPI). The proliferation and migration of AFs were also analyzed.RESULTS:p47phox expression was low in the aortic adventitia but high in the site of intimal injury with continuous hyperlipidic diet. Compared to AFs from wild-type mice, AFs derived from apoE(-/-) mice exhibited elevated NADPH oxidase activity, O2(-) production and higher mRNA and protein levels of p47phox, correlated with increased capability of proliferation and migration. DPI inhibited NADPH oxidase activity and AFs proliferation and migration in a dose-dependent manner. In addition, siRNA mediated knockdown of p47phox attenuated the proliferation and migration of AFs derived from apoE(-/-) mice.CONCLUSION:p47phox plays a critical role in the regulation of adventitial fibroblast proliferation and migration and may be a new therapeutic target for neointimal hyperplasia.
-
The imbalanced redox status in senescent endothelial cells is due to dysregulated Thioredoxin-1 and NADPH oxidase 4
Christine Goy,Philip Czypiorski,Joachim Altschmied,Sascha Jakob,Lothar L Rabanter,Alison C Brewer,Niloofar Ale-Agha,Nadine Dyballa-Rukes,Ajay M Shah,Judith Haendeler
DOI: https://doi.org/10.1016/j.exger.2014.03.005
Abstract:Environmental stressors as well as genetic modifications are known to enhance oxidative stress and aging processes. Mitochondrial and nuclear dysfunctions contribute to the onset of aging. One of the most important redox regulators in primary human endothelial cells is Thioredoxin-1 (Trx-1), a 12 kD protein with additional anti-apoptotic properties. Cellular generators of reactive oxygen species are NADPH oxidases (NOXs), of which NOX4 shows highest expression levels in endothelial cells. Therefore, the aim of the study was to investigate how Trx-1 and NOX4 are regulated during stress-induced premature senescence in endothelial cells. We treated primary human endothelial cells for two weeks with H2O2 to generate stress-induced premature senescence in these cells. In this model senescence-associated β-Galactosidase and nuclear p21 as senescence markers are increased. Moreover, total and mitochondrial reactive oxygen species formation is enhanced. An imbalanced redox homeostasis is detected by elevated NOX4 and decreased Trx-1 levels. This can be rescued by lentiviral expression of Trx-1. Moreover, the lysosomal protease Cathepsin D is over-activated, which results in reduced Trx-1 protein levels. Inhibition of "over-active" Cathepsin D by the specific, cell-permeable inhibitor pepstatin A abolishes the increase in nuclear p21 protein, ROS formation and degradation of Trx-1 protein, thus leading to blockade of stress-induced premature senescence by stabilizing the cellular redox homeostasis. Aortic Trx-1 levels are decreased and Cathepsin D activity is increased in NOX4 transgenic mice exclusively expressing NOX4 in the endothelium when compared to their wildtype littermates. Thus, loss of Trx-1 and upregulation of NOX4 importantly contribute to the imbalance in the redox-status of senescent endothelial cells ex vivo and in vivo.
-
Oxysterols in Vascular Cells and Role in Atherosclerosis
Celine Luquain-Costaz,Isabelle Delton
2024-09-24
Abstract:<div><p>Atherosclerosis is a major cardiovascular complication of diseases associated with elevated oxidative stress such as type 2 diabetes and metabolic syndrome. In these situations, low density lipoproteins (LDL) undergo oxidation. Oxidized LDL display proatherogenic activities through multiple and complex mechanisms which lead to dysfunctions of vascular cells (endothelial cells, smooth muscle cells and macrophages). Oxidized LDL are enriched in oxidized products of cholesterol called oxysterols formed either by autoxidation, enzymatically, or by both mechanisms. Several oxysterols have been shown to accumulate in atheroma plaques and to play a key role in atherogenesis. Depending on the type of oxysterols, various biological effects are exerted on vascular cells to regulate the formation of macrophage foam cells, endothelial integrity, adhesion and transmigration of monocytes, plaque progression and instability. Most of these effects are linked to the ability of oxysterols to induce cellular oxidative stress and cytotoxicity mainly through apoptosis and proinflammatory mediators. Like for excess cholesterol, high density lipoproteins (HDL) can exert antiatherogenic activity stimulating the efflux of oxysterols that have accumulated in foamy macrophages.</p></div>
Biomolecules